Marked effect of larotrectinib on primary cutaneous secretory carcinoma: A case report. Hayakawa K, Irisawa R, Umefune R, Mae K, et al. J Dermatol 2024 Apr 11. doi: 10.1111/1346-8138.17218.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Hayakawa K, Irisawa R, Umefune R, Mae K, et al. Marked effect of larotrectinib on primary cutaneous secretory carcinoma: A case report. J Dermatol 2024 Apr 11. doi: 10.1111/1346-8138.17218.
PMID: 38605458